NYC startupfromWIRED2 months agoTrump's FDA Cuts Are Putting Drug Development at RiskStaffing cuts at the FDA may hinder the timely development and approval of new drugs.
Artificial intelligencefromWIRED3 weeks agoOpenAI and the FDA Are Holding Talks About Using AI In Drug EvaluationFDA is exploring AI technologies to expedite drug approval processes.AI-assisted reviews could potentially modernize the drug approval timeline.
NYC startupfromWIRED2 months agoTrump's FDA Cuts Are Putting Drug Development at RiskStaffing cuts at the FDA may hinder the timely development and approval of new drugs.
Artificial intelligencefromWIRED3 weeks agoOpenAI and the FDA Are Holding Talks About Using AI In Drug EvaluationFDA is exploring AI technologies to expedite drug approval processes.AI-assisted reviews could potentially modernize the drug approval timeline.
Intellectual property lawfromIPWatchdog.com | Patents & Intellectual Property Law3 weeks agoFederal Circuit Reverses Injunction Against Avadel Due to Hatch-Waxman Safe HarborFederal Circuit overturned injunction, allowing Avadel to conduct pre-approval activities for Lumryz under Hatch-Waxman 'safe harbor'.
Artificial intelligencefromNature1 month agoThe future of Alzheimer's treatmentRecent approvals of anti-amyloid drugs provide hope in Alzheimer's treatment, although their modest effectiveness remains a topic of debate.
Alternative medicinefromwww.bournemouthecho.co.uk2 months agoNHS approves new pill that will 'transform' the treatment of endometriosisA new combination drug, Ryeqo, offers effective treatment for endometriosis with convenience and affordability for patients.